| 51 |
26069066 | [The couple fibroblast growth factor 23 (FGF23)/Klotho]. | 2015 May-Jun |
1 |
| 52 |
26347327 | Significant roles of anti-aging protein klotho and fibroblast growth factor23 in cardiovascular disease. | 2015 Jul |
2 |
| 53 |
23647316 | Reciprocal regulation of calcium-/phosphate-regulating hormones in cyclists during the Giro d'Italia 3-week stage race. | 2014 Oct |
2 |
| 54 |
23713873 | Therapeutic use of calcitriol. | 2014 Mar |
3 |
| 55 |
24057685 | A short story of Klotho and FGF23: a deuce of dark side or the savior? | 2014 Mar |
1 |
| 56 |
24553631 | Renal osteodystrophy in children: pathogenesis, diagnosis and treatment. | 2014 Apr |
1 |
| 57 |
24875546 | Enigmatic Cassandra: renal FGF23 formation in polycystic kidney disease. | 2014 Jun |
2 |
| 58 |
25198236 | Changes of fibroblast growth factor 23 (FGF23) levels following calcitriol treatment in a vitamin D deficient patient. | 2014 Sep |
2 |
| 59 |
23263654 | 1,25-dihydroxyvitamin D(3) regulation of fibroblast growth factor-23 expression in bone cells: evidence for primary and secondary mechanisms modulated by leptin and interleukin-6. | 2013 Apr |
1 |
| 60 |
23281842 | Ergocalciferol treatment and aspects of mineral homeostasis in patients with chronic kidney disease stage 4-5. | 2013 Mar |
2 |
| 61 |
23505057 | Effects of iron deficiency anemia and its treatment on fibroblast growth factor 23 and phosphate homeostasis in women. | 2013 Aug |
1 |
| 62 |
23677707 | Correction of hypocalcemia allows optimal recruitment of FGF-23-dependent phosphaturic mechanisms in acute hyperphosphatemia post-phosphate enema. | 2013 Nov |
1 |
| 63 |
23771921 | Fibroblast growth factor 23, bone mineral density, and risk of hip fracture among older adults: the cardiovascular health study. | 2013 Aug |
2 |
| 64 |
23825530 | Plasma fibroblast growth factor 23 concentration is increased and predicts mortality in patients on the liver-transplant waiting list. | 2013 |
1 |
| 65 |
23852336 | FGF23 and mineral metabolism in the early post-renal transplantation period. | 2013 Nov |
1 |
| 66 |
23877588 | FGF-23 and secondary hyperparathyroidism in chronic kidney disease. | 2013 Nov |
1 |
| 67 |
24096965 | Growth hormone and Klotho. | 2013 Nov |
1 |
| 68 |
24247665 | 25-Hydroxyvitamin D3 1-α-hydroxylase-dependent stimulation of renal klotho expression by spironolactone. | 2013 |
1 |
| 69 |
22006791 | A Phex mutation in a murine model of X-linked hypophosphatemia alters phosphate responsiveness of bone cells. | 2012 Feb |
1 |
| 70 |
22383746 | Daily variability in mineral metabolites in CKD and effects of dietary calcium and calcitriol. | 2012 May |
2 |
| 71 |
22396166 | FGF23 in chronic kidney disease. | 2012 |
1 |
| 72 |
22483462 | Elevated fibroblast growth factor 23 levels as a cause of early post-renal transplantation hypophosphatemia. | 2012 Apr |
2 |
| 73 |
23018879 | Earlier decrease of FGF-23 and less hypophosphatemia in preemptive kidney transplant recipients. | 2012 Oct 27 |
1 |
| 74 |
23146451 | Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation. | 2012 Nov |
3 |
| 75 |
23214203 | Fibroblast growth factor 23--structure, function and role in kidney diseases. | 2012 May-Jun |
3 |
| 76 |
23256830 | [Vitamin D metabolism and current options for therapeutic activation of vitamin D receptor in patients with chronic kidney disease or renal failure]. | 2012 Nov |
1 |
| 77 |
26069775 | Oncogenic osteomalacia illustrating the effect of fibroblast growth factor 23 on phosphate homeostasis. | 2012 Jun |
2 |
| 78 |
20689328 | Fibroblast growth factor 23 in hemodialysis patients: effects of phosphate binder, calcitriol and calcium concentration in the dialysate. | 2011 |
1 |
| 79 |
20861820 | Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism. | 2011 Jan |
2 |
| 80 |
20946192 | Tertiary excess of fibroblast growth factor 23 and hypophosphatemia following kidney transplantation. | 2011 Feb |
1 |
| 81 |
21193927 | Clinical practice. Fibroblast growth factor (FGF)23: a new hormone. | 2011 May |
2 |
| 82 |
21265930 | Fibroblast growth factor 23 in chronic kidney disease: New insights and clinical implications. | 2011 Mar |
1 |
| 83 |
21273150 | [Phosphocalcic metabolism: regulation and explorations]. | 2011 Apr |
2 |
| 84 |
21324311 | Instability of fibroblast growth factor-23 (FGF-23): implications for clinical studies. | 2011 May 12 |
2 |
| 85 |
21346724 | Phosphate and FGF-23. | 2011 Apr |
1 |
| 86 |
21496980 | Role of Klotho in aging, phosphate metabolism, and CKD. | 2011 Jul |
1 |
| 87 |
21786227 | What would we like to know, and what do we not know about fibroblast growth factor 23? | 2011 Nov-Dec |
1 |
| 88 |
21841832 | Three feedback loops precisely regulating serum phosphate concentration. | 2011 Sep |
3 |
| 89 |
21852584 | Cross talk between the renin-angiotensin-aldosterone system and vitamin D-FGF-23-klotho in chronic kidney disease. | 2011 Sep |
1 |
| 90 |
21959717 | Chronic kidney disease--mineral and bone disorder: a complex scenario. | 2011 |
1 |
| 91 |
26746858 | Phosphate and FGF-23. | 2011 Apr |
1 |
| 92 |
19965548 | Effects of cinacalcet and concurrent low-dose vitamin D on FGF23 levels in ESRD. | 2010 Jan |
1 |
| 93 |
20157195 | Treatment of X-linked hypophosphatemia with calcitriol and phosphate increases circulating fibroblast growth factor 23 concentrations. | 2010 Apr |
4 |
| 94 |
20180772 | The fibroblast growth factor 23: a new player in the field of cardiovascular, bone and renal disease. | 2010 May |
2 |
| 95 |
20507943 | Forging forward with 10 burning questions on FGF23 in kidney disease. | 2010 Sep |
1 |
| 96 |
20571400 | Estrogens and bone disease in chronic kidney disease: role of FGF23. | 2010 Jul |
1 |
| 97 |
20599669 | The bone and the kidney. | 2010 Nov 1 |
1 |
| 98 |
20628536 | Model-Based Analysis of FGF23 Regulation in Chronic Kidney Disease. | 2010 Jun 9 |
1 |
| 99 |
20675303 | Altered renal FGF23-mediated activity involving MAPK and Wnt: effects of the Hyp mutation. | 2010 Oct |
1 |
| 100 |
20732956 | Effects of vitamin D replacement therapy on serum FGF23 concentrations in vitamin D-deficient women in short term. | 2010 Nov |
1 |